Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 4404 siguiente >>
Presentar resultados
Seleccionar todas
2. Cita con resumen
Anónimo. UK grants sildenafil over-the-counter status. DIA Daily 2017:2. [Ref.ID 102150]
3. Cita con resumen
Samper E. La estafa de la homeopatía: en crisis. eldiario.es 2017:1. [Ref.ID 102149]
4. Cita con resumen
Poluzzi E, Diemberger I, de Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Ulrichsen SP, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G. Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. Eur J Clin Pharmacol 2017;73:1499-510. [Ref.ID 102126]
5. Cita con resumen
Hawkes N. Statin initiation is unrelated to cardiovascular risk score, finds study.. BMJ 2017;359:j4898. [Ref.ID 102110]
6.Tiene citas relacionadas Cita con resumen
Socías ME, Wood E. Epidemic of deaths from fentanyl overdose. BMJ 2017;359:j4355. [Ref.ID 102107]
8.Tiene citas relacionadas Cita con resumen
Gieling EM, van den Ham HA, van Onzenoort H, Bos J, Kramers C, de Boer A, de Vries F, Burden AM. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study. Br J Clin Pharmacol 2017;83:1844-59. [Ref.ID 102014]
9. Cita con resumen
Iacobucci G. NHS to stop funding homeopathy and some drugs in targeted savings drive. BMJ 2017;358:j3560. [Ref.ID 102013]
11. Cita con resumen
Zaman MJ. Cost saving is nothing to be proud of. BMJ 2017;358:j3428. [Ref.ID 101978]
12. Cita con resumen
Raffel J, Wallace A, Gveric D, Reynolds R, Friede T, Nicholas R. Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29. PLOS Medicine 2017:10 de julio. [Ref.ID 101977]
13. Cita con resumen
Castellsague J, Perez-Gutthann S, Calingaert B, Bui C, Varas-Lorenzo C, Arana A, Prados-Torres A, Poblador-Plou B, Gonzlez-Rubio F, Giner-Soriano M, Roso-Llorach A, Linder M, Citarella A, Scholle O, Blenk T, Garbe E. Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany. Pharmacoepidemiol Drug Saf 2017;26:615-24. [Ref.ID 101961]
14. Cita con resumen
Mackenzie IS, Morant SV, Wei L, Thompson AM, MacDonald TM. Spironolactone use and risk of incident cancers: a retrospective, matched cohort study. Br J Clin Pharmacol 2017;83:653-63. [Ref.ID 101935]
15. Cita con resumen
Anónimo. More doctors disclose payments from drug companies . BMJ 2017;358:30 de junio. [Ref.ID 101667]
16.Tiene citas relacionadas Cita con resumen
Hawkes N. Are new hepatitis C drugs all they’re cracked up to be?. BMJ 2017;357:j2961. [Ref.ID 101659]
17. Cita con resumen
Dondo TB, Hall M, West RM, Jemberg T, Lindahl B, Bueno H, Danchin N. ß-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. J Am Coll Cardiol 2017;69:2710-20. [Ref.ID 101613]
18. Cita con resumen
Anónimo. UK’s NICE approves pembrolizumab for untreated lung cancer patients. DIA Daily 2017:1. [Ref.ID 101612]
19. Cita con resumen
Anónimo. Finasteride: rare reports of depression and suicidal thoughts. Drug Safety Update 2017;10:2-3. [Ref.ID 101600]
20.Enlace a cita originalTiene citas relacionadas
Valente M, Bhandari S. Renal function after new treatment with renin-angiotensin system blockers. BMJ 2017;356:j1122. [Ref.ID 101474]
Seleccionar todas
 
 1 a 20 de 4404 siguiente >>